- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Instruments
Boston Scientific Corp
+ Add to WatchlistBSX:US
9.1300 USD 0.1000 1.08%As of 20:04:03 ET on 05/22/2013.
Snapshot for Boston Scientific Corp (BSX)
| Open: | 9.2500 | Day's Range: | 9.1000 - 9.3400 | Volume: | 32,703,792 |
|---|---|---|---|---|---|
| Previous Close: | 9.1300 | 52wk Range: | 4.7900 - 9.3900 | 1-Yr Rtn: | +54.48% |
Key Statistics for BSX
| Current P/E Ratio (ttm) | 22.1731 |
|---|---|
| Estimated P/E(12/2013) | 22.2141 |
| Relative P/E vs. SPX | 1.3723 |
| Earnings Per Share (USD) (ttm) | 0.4118 |
| Est. EPS (USD) (12/2013) | 0.4110 |
| Est. PEG Ratio | 2.5507 |
| Market Cap (M USD) | 12,317.21 |
| Shares Outstanding (M) | 1,349.09 |
| 30 Day Average Volume | 20,652,354 |
| Price/Book (mrq) | 1.8959 |
| Price/Sale (ttm) | 1.7673 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/26/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BSX
Company Profile & Key Executives for BSX
Boston Scientific Corporation develops, manufactures, and markets minimally invasive medical devices. The Company's products are used in interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, urology, gynecology and neuromodulation.
| Michael F Mahoney "Mike"President/CEO | Jeffrey D CapelloExec VP/CFO |
| Timothy A PrattExec VP/CAO/Secy/Gen Cnsl | Keith D DawkinsExec VP/Chief Medical Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
BSX News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page